Xilio Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 02, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $100,500,000
Company Info
- Founders
- Rene Russo
- Company Description
- Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
- Market
- Cancer Immunotherapy
- Location
- Waltham, MA, USA
- Coinvestors
- Atlas Venture, Bay City Capital, F-Prime Capital Partners, Ipsen, M Ventures, MRL Ventures Fund, RiverVest Venture Partners, Solasta Ventures, SV Health Investors, Takeda Ventures